Is Emergent BioSolutions Stock a Buy?
The public crisis that is the COVID-19 pandemic has some companies scrambling to survive, and others working hard to contribute to solving the problem. Investors, meanwhile, are dumping stocks of the companies in the former category while optimistically buying up shares of companies that might somehow profit from the tragedy.
Emergent BioSolutions (NYSE: EBS) is a biotechnology company that specializes in drugs, vaccines, and medical devices to address public health threats, which COVID-19 most certainly is. The share price has managed to hold its own in a woeful market, partly because the company is working on solutions to the pandemic. But is the stock a buy now?
Image source: Getty Images.
Source Fool.com
